Search

everythinglearnresearchcommunity

for

Search:↓

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Animal research has greatly advanced dermatology.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Aesthetic rehabilitation techniques can improve life quality and wellbeing for disabled patients.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Biotin supplements are generally ineffective in preventing hair loss after sleeve gastrectomy.

Terbinafine can cause hair loss.

Cyclosporin doesn't stop hair loss.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Chemokine signaling is important for hair development.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Suppressing certain hormones might help prevent prostate cancer.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Two finasteride tablet types are equally effective and can be swapped.

Tph cells are linked to the severity of systemic lupus erythematosus.

Proper periodontal treatment with xenograft effectively manages aggressive periodontitis in SLE patients.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher antigliadin antibody levels are linked to alopecia areata severity.